FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386243669> ?p ?o ?g. }

• W4386243669 endingPage "763" @default.
• W4386243669 startingPage "756" @default.
• W4386243669 abstract "Although intravenous (IV) direct thrombin inhibitors (DTI) have gained interest in pediatric extracorporeal membrane oxygenation (ECMO), dosing and safety information is limited. The objective of this systematic review was to characterize DTI types, dosing, monitoring, and outcomes (bleeding and thromboembolic) in pediatric ECMO patients managed with IV DTIs. We conducted searches of MEDLINE (Ovid) and Embase (Elsevier) from inception through December 2022. Case reports, retrospective studies, and prospective studies providing per-patients or summary data for patient(s) <18 years of age receiving IV DTI for ECMO anticoagulation were included. Study selection and data extraction were conducted independently by two reviewers. A total of 28 studies: 14 case reports, 13 retrospective studies, and 1 prospective study were included, totaling 329 patients. Bivalirudin was utilized in 318 (96.7%), argatroban in 9 (2.7%), and lepirudin in 2 (0.6%) patients. Infusion dosing included: bivalirudin 0.14 ± 0.37 mg/kg/h, argatroban 0.69 ± 0.73 µg/kg/min, lepirudin 0.14 ± 0.02 mg/kg/h. Laboratory monitoring tests utilized were the activated clotting time, activated partial thromboplastin time (aPTT), diluted thrombin time, and thromboelastography measures. The aPTT was utilized in most patients (95%). Thromboembolism, bleeding, or death were observed in 17%, 17%, and 23% of bivalirudin, argatroban, and lepirudin patients, respectively. Bivalirudin appears to be the most frequently used DTI in pediatric ECMO. Dosing and laboratory monitoring varied, and bleeding and thromboembolic events were reported in 17% of patients. Prospective studies are warranted to establish dosing, monitoring, safety, and efficacy of bivalirudin and other IV DTI in pediatric ECMO." @default.
• W4386243669 created "2023-08-30" @default.
• W4386243669 creator A5010545449 @default.
• W4386243669 creator A5021997989 @default.
• W4386243669 creator A5043651595 @default.
• W4386243669 creator A5050431046 @default.
• W4386243669 creator A5083062306 @default.
• W4386243669 date "2023-08-29" @default.
• W4386243669 modified "2023-10-14" @default.
• W4386243669 title "Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature" @default.
• W4386243669 cites W1523598805 @default.
• W4386243669 cites W1564175447 @default.
• W4386243669 cites W1917745042 @default.
• W4386243669 cites W1965593113 @default.
• W4386243669 cites W1971656405 @default.
• W4386243669 cites W1986420206 @default.
• W4386243669 cites W1999841380 @default.
• W4386243669 cites W2019467074 @default.
• W4386243669 cites W2068884110 @default.
• W4386243669 cites W2071092849 @default.
• W4386243669 cites W2107508927 @default.
• W4386243669 cites W2123167192 @default.
• W4386243669 cites W2125743489 @default.
• W4386243669 cites W2133100310 @default.
• W4386243669 cites W2133513556 @default.
• W4386243669 cites W2144462467 @default.
• W4386243669 cites W2152245163 @default.
• W4386243669 cites W2346357667 @default.
• W4386243669 cites W2415712239 @default.
• W4386243669 cites W2768399284 @default.
• W4386243669 cites W2787570193 @default.
• W4386243669 cites W2801382910 @default.
• W4386243669 cites W2905638541 @default.
• W4386243669 cites W2906315434 @default.
• W4386243669 cites W2909739567 @default.
• W4386243669 cites W2986707568 @default.
• W4386243669 cites W2989732371 @default.
• W4386243669 cites W2996045162 @default.
• W4386243669 cites W3024837474 @default.
• W4386243669 cites W3036956358 @default.
• W4386243669 cites W3037954915 @default.
• W4386243669 cites W3043929122 @default.
• W4386243669 cites W3088296392 @default.
• W4386243669 cites W3092388653 @default.
• W4386243669 cites W3136364157 @default.
• W4386243669 cites W3152790783 @default.
• W4386243669 cites W3184524684 @default.
• W4386243669 cites W3189124964 @default.
• W4386243669 cites W4205469447 @default.
• W4386243669 cites W4220710199 @default.
• W4386243669 cites W4225394982 @default.
• W4386243669 cites W4290069219 @default.
• W4386243669 cites W4306153835 @default.
• W4386243669 cites W4385370232 @default.
• W4386243669 doi "https://doi.org/10.1055/s-0043-1772838" @default.
• W4386243669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37643746" @default.
• W4386243669 hasPublicationYear "2023" @default.
• W4386243669 type Work @default.
• W4386243669 citedByCount "1" @default.
• W4386243669 countsByYear W43862436692023 @default.
• W4386243669 crossrefType "journal-article" @default.
• W4386243669 hasAuthorship W4386243669A5010545449 @default.
• W4386243669 hasAuthorship W4386243669A5021997989 @default.
• W4386243669 hasAuthorship W4386243669A5043651595 @default.
• W4386243669 hasAuthorship W4386243669A5050431046 @default.
• W4386243669 hasAuthorship W4386243669A5083062306 @default.
• W4386243669 hasConcept C126322002 @default.
• W4386243669 hasConcept C141071460 @default.
• W4386243669 hasConcept C167135981 @default.
• W4386243669 hasConcept C2776301958 @default.
• W4386243669 hasConcept C2776472838 @default.
• W4386243669 hasConcept C2776710957 @default.
• W4386243669 hasConcept C2776858399 @default.
• W4386243669 hasConcept C2777288759 @default.
• W4386243669 hasConcept C2777292125 @default.
• W4386243669 hasConcept C2777557582 @default.
• W4386243669 hasConcept C2777565915 @default.
• W4386243669 hasConcept C2777664302 @default.
• W4386243669 hasConcept C2778261982 @default.
• W4386243669 hasConcept C2778810321 @default.
• W4386243669 hasConcept C2779161974 @default.
• W4386243669 hasConcept C2779612170 @default.
• W4386243669 hasConcept C2780205058 @default.
• W4386243669 hasConcept C2780400711 @default.
• W4386243669 hasConcept C42219234 @default.
• W4386243669 hasConcept C500558357 @default.
• W4386243669 hasConcept C57002609 @default.
• W4386243669 hasConcept C71924100 @default.
• W4386243669 hasConcept C89560881 @default.
• W4386243669 hasConceptScore W4386243669C126322002 @default.
• W4386243669 hasConceptScore W4386243669C141071460 @default.
• W4386243669 hasConceptScore W4386243669C167135981 @default.
• W4386243669 hasConceptScore W4386243669C2776301958 @default.
• W4386243669 hasConceptScore W4386243669C2776472838 @default.
• W4386243669 hasConceptScore W4386243669C2776710957 @default.
• W4386243669 hasConceptScore W4386243669C2776858399 @default.
• W4386243669 hasConceptScore W4386243669C2777288759 @default.
• W4386243669 hasConceptScore W4386243669C2777292125 @default.

• next